The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

KEFAMAST Dry Cow Intramammary Suspension

500/500 mg/syringe Intramammary suspension

Bimeda Animal Health LimitedVPA22033/041/001

Main Information

Trade NameKEFAMAST Dry Cow Intramammary Suspension
Active SubstancesCefalexin
Strength500/500 mg/syringe
Dosage FormIntramammary suspension
Licence HolderBimeda Animal Health Limited
Licence NumberVPA22033/041/001

Group Information

ATC CodeQJ51RD01 cefalexin, combinations with other antibacterials
Therapeutic ClassAntibacterial


Licence Issued01/10/1988
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back